I'm wondering (read this somewhere just can't remember where) if getting the pneumonia vac NOW would relieve some of the problem or concern with the H1N1 turning deadly.
I think its a definite maybe whether the pneumonia vaccine may help limit swine flu deaths.
Some doctors say it may help some say it may not but overall many believe it can't hurt. I thought this whole article was interesting. There is much more that I didnt copy and paste.
"We would certainly like to see the vaccine used more extensively," said Dr. William Schaffner, chairman of the preventive medicine department at Vanderbilt University School of Medicine and president-elect of the National Foundation for Infectious Diseases.
U.S. sales of Pneumovax have not increased since June, according to John D. Grabenstein, senior director of Adult Vaccine Medical Affairs for Merck Vaccines and Infectious Diseases. Sales in Europe have risen, however, in response to similar recommendations by health authorities there.
Further, the vaccine provides protection against pneumonia for up to 10 years, meaning one vaccination provides at least some safeguard not just this year but for future flu seasons as well.
Some physicians are more skeptical about the pneumococcal vaccine's potential to limit flu deaths.
The problem is that there are many causes of pneumonia, an inflammation of the lungs that interferes with breathing and can be fatal. The influenza virus itself can cause pneumonia, as can many others. Or the lungs can be invaded by a bacterium such as Streptococcus pneumoniae or Staphylococcus aureus when the patient is weakened by a viral infection. Pneumovax protects against 23 strains of S. pneumoniae.
It is not yet clear what proportion of swine-flu-related pneumonia is caused by S. pneumoniae and thus could be prevented or ameliorated by immunization.
"I am not aware of any data suggesting that . . . pregnant women are at increased risk of pneumonia, whether during a pandemic or not," Moore said. In fact, most of the pregnant women who have died from pandemic flu have suffered viral pneumonia, for which Pneumovax offers no protection.
Dr. Linda Rosenstock, dean of UCLA's School of Public Health, speculates that Pneumovax has not been promoted more heavily because the H1N1 pandemic has so far been perceived to be milder than seasonal flu. If the virus mutates to become more deadly, then the recommendations will become stronger, she believes.
http://www.latimes.com/features/health/la-sci-pneumonia4-2009aug04,0,6872284.story